Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. In our 2024-25 Innovation Seed Grant competition, the Centre funded...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The fourth annual Ted Rogers Centre Heart Failure Symposium unfolded May 3-4 in downtown Toronto, held for the first time in conjunction with the Michael J. Sole Cardiovascular Scientific Day.
International experts who joined this year’s faculty included Dr. Christine Seidman, director of the Cardiovascular Genetics Program at Brigham and Women’s Hospital, Harvard radiology professor Peter Caravan, Dr. Sanjay Rajagopalan, chief of cardiology at Case Western Reserve University, Mount Sinai’s Dr. Robert Rosenson, and Dr. Junichi Sadoshima, a world leader in the field of cardiac growth and survival signaling at Rutgers University.
With over 380 participants, this is Canada’s leading conference on heart failure: thank you to all faculty, sponsors and attendees for your participation. If you missed this event, presentations will live on our YouTube channel.
New for 2019: Our program on Saturday, May 4th was devoted to the role of primary care physicians in the management and prevention of heart failure.
Experts from seven Toronto hospitals explored a range of topics, from translating a cardiology consult to the use of ECHO to genetic testing to helping patients with type 2 diabetes and renal disease prevent the onset of heart failure.
Stay tuned for news on our 2020 event later this summer.
For all the details, visit https://www.trchrsymposium.ca
